Elda Lopez, MD
Child & Adolescent Psychiatry · Miami, FLNPI 1538141809
Payments from drug & device makers
Across 77 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$549
- Tris Pharma Inc$381
- Neos Therapeutics, LP$144
- Adlon Therapeutics L.p.$77
- Ironshore Pharmaceuticals Inc.$66
- Lundbeck LLC$61
- plus $132 from 3 others
What the payments were for
- Food & beverage$1,411100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $549 |
| Tris Pharma Inc | 20 | $381 |
| Neos Therapeutics, LP | 8 | $144 |
| Adlon Therapeutics L.p. | 4 | $77 |
| Ironshore Pharmaceuticals Inc. | 4 | $66 |
| Lundbeck LLC | 3 | $61 |
| Shire North American Group Inc | 3 | $51 |
| Corium, LLC | 2 | $51 |
| Johnson & Johnson | 2 | $31 |
How this compares
$1,411 in reported general payments places this provider in the 65th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 69 | $8,660 |
| Vilazodone Hcl | 64 | $6,195 |
| Memantine Hcl ErMemantine Hcl | 50 | $3,668 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 268 | $3,621 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 31 | $3,297 |
| Bupropion XlBupropion Hcl | 182 | $2,674 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 88 | $2,549 |
| Buspirone Hcl | 276 | $2,317 |
| Eszopiclone | 39 | $1,430 |
| Lamotrigine | 162 | $1,217 |
| Temazepam | 19 | $1,195 |
| Escitalopram Oxalate | 151 | $937 |
| Olanzapine | 27 | $932 |
| Memantine Hcl | 42 | $698 |
| Mirtazapine | 63 | $687 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Miami
- Americo PadillaMiami$1.6M
- Jose AlvarezMiami$229K
- Sean HoranMiami$17K
- Nicole RedondoMiami$4K
- Gilbert SmithMiami$4K
- Jonathan ParkerMiami$4K
- Janeris LoredoMiami$3K
- Jerome SiegmeisterMiami$3K
- Mauricio RodriguezMiami$3K
- Yasin BezMiami$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.